CN101607000A - 七味通脉热敷贴及其对输液性静脉炎的防治 - Google Patents
七味通脉热敷贴及其对输液性静脉炎的防治 Download PDFInfo
- Publication number
- CN101607000A CN101607000A CNA2009100144261A CN200910014426A CN101607000A CN 101607000 A CN101607000 A CN 101607000A CN A2009100144261 A CNA2009100144261 A CN A2009100144261A CN 200910014426 A CN200910014426 A CN 200910014426A CN 101607000 A CN101607000 A CN 101607000A
- Authority
- CN
- China
- Prior art keywords
- bag
- phlebitis
- tincture
- blood circulation
- chinese medicine
- Prior art date
Links
- 208000001297 Phlebitis Diseases 0.000 title claims abstract description 22
- 230000017531 blood circulation Effects 0.000 title claims abstract description 18
- 239000000796 flavoring agents Substances 0.000 title claims abstract description 15
- 235000019634 flavors Nutrition 0.000 title claims abstract description 15
- 239000003814 drugs Substances 0.000 claims abstract description 44
- 229940098465 Tincture Drugs 0.000 claims abstract description 16
- 230000000694 effects Effects 0.000 claims abstract description 14
- 238000010438 heat treatment Methods 0.000 claims abstract description 14
- 239000008280 blood Substances 0.000 claims abstract description 13
- 210000004369 Blood Anatomy 0.000 claims abstract description 12
- 230000001737 promoting Effects 0.000 claims abstract description 10
- 210000000214 Mouth Anatomy 0.000 claims abstract description 7
- 229940079593 drugs Drugs 0.000 claims abstract description 7
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 230000002522 swelling Effects 0.000 claims abstract description 7
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 6
- 239000007815 EtOH Substances 0.000 claims abstract description 5
- 239000002390 adhesive tape Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 230000002459 sustained Effects 0.000 claims abstract description 3
- 201000010099 diseases Diseases 0.000 abstract description 7
- 230000002045 lasting Effects 0.000 abstract description 4
- 238000005516 engineering processes Methods 0.000 abstract description 3
- 229920003023 plastics Polymers 0.000 abstract description 3
- 238000002360 preparation methods Methods 0.000 abstract description 2
- 238000007789 sealing Methods 0.000 abstract description 2
- 238000007670 refining Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
- 210000004204 Blood Vessels Anatomy 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 206010061218 Inflammation Diseases 0.000 description 3
- 230000004054 inflammatory processes Effects 0.000 description 3
- 230000000474 nursing Effects 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 210000003491 Skin Anatomy 0.000 description 2
- 230000003110 anti-inflammatory Effects 0.000 description 2
- 281999990011 institutions and organizations companies 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- OENIXTHWZWFYIV-UHFFFAOYSA-N 2-[4-[2-[5-(cyclopentylmethyl)-1H-imidazol-2-yl]ethyl]phenyl]benzoic acid Chemical compound data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='300px' height='300px' viewBox='0 0 300 300'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='300' height='300' x='0' y='0'> </rect>
<path class='bond-0' d='M 50.7536,180.903 L 54.4902,174.224' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0' d='M 54.4902,174.224 L 58.2269,167.546' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 58.2566,169.75 L 66.4582,169.639' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 66.4582,169.639 L 74.6597,169.529' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 58.1972,165.342 L 66.3987,165.232' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 66.3987,165.232 L 74.6003,165.121' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2' d='M 58.2269,167.546 L 46.9506,148.609' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3' d='M 46.9506,148.609 L 24.9126,148.906' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3' d='M 43.5855,144.246 L 28.1589,144.454' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27' d='M 46.9506,148.609 L 57.7123,129.375' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4' d='M 24.9126,148.906 L 13.6364,129.969' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5' d='M 13.6364,129.969 L 24.398,110.735' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5' d='M 19.0974,129.236 L 26.6306,115.773' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6' d='M 24.398,110.735 L 46.436,110.438' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7' d='M 46.436,110.438 L 57.7123,129.375' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7' d='M 44.3401,115.534 L 52.2334,128.79' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8' d='M 57.7123,129.375 L 79.7502,129.078' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9' d='M 79.7502,129.078 L 91.0265,148.015' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9' d='M 85.229,129.663 L 93.1224,142.919' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11' d='M 79.7502,129.078 L 90.5119,109.844' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10' d='M 91.0265,148.015 L 113.064,147.718' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28' d='M 113.064,147.718 L 123.826,128.484' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28' d='M 110.832,142.68 L 118.365,129.216' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12' d='M 90.5119,109.844 L 112.55,109.547' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12' d='M 93.877,114.207 L 109.304,113.999' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13' d='M 112.55,109.547 L 123.826,128.484' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14' d='M 123.826,128.484 L 145.864,128.187' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15' d='M 145.864,128.187 L 157.14,147.123' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16' d='M 157.14,147.123 L 179.178,146.826' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17' d='M 179.178,146.826 L 183.46,140.763' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17' d='M 183.46,140.763 L 187.741,134.7' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 179.178,146.826 L 183.579,152.715' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 183.579,152.715 L 187.98,158.603' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 184.029,145.954 L 187.11,150.076' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 187.11,150.076 L 190.19,154.198' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29' d='M 197.279,130.493 L 205.111,132.922' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29' d='M 205.111,132.922 L 212.943,135.35' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19' d='M 197.76,162.65 L 205.5,160.019' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19' d='M 205.5,160.019 L 213.24,157.388' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20' d='M 213.24,157.388 L 212.943,135.35' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20' d='M 208.788,154.142 L 208.58,138.715' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21' d='M 212.943,135.35 L 230.597,122.156' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22' d='M 230.597,122.156 L 250.851,130.848' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23' d='M 250.851,130.848 L 269.787,119.572' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-30' d='M 250.851,130.848 L 255.723,152.343' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24' d='M 269.787,119.572 L 286.364,134.098' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25' d='M 286.364,134.098 L 277.671,154.351' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26' d='M 277.671,154.351 L 255.723,152.343' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text dominant-baseline="central" text-anchor="end" x='50.1613' y='187.882' style='font-size:7px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#E84235' ><tspan>HO</tspan></text>
<text dominant-baseline="central" text-anchor="start" x='77.5687' y='168.351' style='font-size:7px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#E84235' ><tspan>O</tspan></text>
<text dominant-baseline="central" text-anchor="middle" x='191.891' y='129.925' style='font-size:7px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#4284F4' ><tspan>N</tspan></text>
<text dominant-baseline="central" text-anchor="start" x='189.442' y='122.578' style='font-size:7px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#4284F4' ><tspan>H</tspan></text>
<text dominant-baseline="central" text-anchor="middle" x='192.372' y='165.583' style='font-size:7px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#4284F4' ><tspan>N</tspan></text>
</svg>
 data:image/svg+xml;base64,<?xml version='1.0' encoding='iso-8859-1'?>
<svg version='1.1' baseProfile='full'
              xmlns='http://www.w3.org/2000/svg'
                      xmlns:rdkit='http://www.rdkit.org/xml'
                      xmlns:xlink='http://www.w3.org/1999/xlink'
                  xml:space='preserve'
width='85px' height='85px' viewBox='0 0 85 85'>
<!-- END OF HEADER -->
<rect style='opacity:1.0;fill:#FFFFFF;stroke:none' width='85' height='85' x='0' y='0'> </rect>
<path class='bond-0' d='M 13.5308,51.3802 L 14.7642,49.1758' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-0' d='M 14.7642,49.1758 L 15.9976,46.9713' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 16.006,47.5957 L 18.642,47.5602' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 18.642,47.5602 L 21.2781,47.5247' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 15.9892,46.3469 L 18.6252,46.3114' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-1' d='M 18.6252,46.3114 L 21.2612,46.2758' style='fill:none;fill-rule:evenodd;stroke:#E84235;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-2' d='M 15.9976,46.9713 L 12.8027,41.6059' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3' d='M 12.8027,41.6059 L 6.55858,41.6901' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-3' d='M 11.8492,40.3697 L 7.47836,40.4286' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-27' d='M 12.8027,41.6059 L 15.8518,36.1563' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-4' d='M 6.55858,41.6901 L 3.36364,36.3246' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5' d='M 3.36364,36.3246 L 6.41278,30.875' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-5' d='M 4.91093,36.117 L 7.04533,32.3023' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-6' d='M 6.41278,30.875 L 12.6569,30.7908' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7' d='M 12.6569,30.7908 L 15.8518,36.1563' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-7' d='M 12.063,32.2346 L 14.2995,35.9904' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-8' d='M 15.8518,36.1563 L 22.0959,36.0721' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9' d='M 22.0959,36.0721 L 25.2908,41.4375' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-9' d='M 23.6482,36.2379 L 25.8847,39.9937' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-11' d='M 22.0959,36.0721 L 25.145,30.6224' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-10' d='M 25.2908,41.4375 L 31.5349,41.3533' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28' d='M 31.5349,41.3533 L 34.5841,35.9037' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-28' d='M 30.9024,39.9261 L 33.0368,36.1113' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12' d='M 25.145,30.6224 L 31.3891,30.5383' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-12' d='M 26.0985,31.8586 L 30.4693,31.7997' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-13' d='M 31.3891,30.5383 L 34.5841,35.9037' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-14' d='M 34.5841,35.9037 L 40.8281,35.8195' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-15' d='M 40.8281,35.8195 L 44.0231,41.185' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-16' d='M 44.0231,41.185 L 50.2672,41.1008' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17' d='M 50.2672,41.1008 L 51.7007,39.0707' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-17' d='M 51.7007,39.0707 L 53.1343,37.0405' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 50.2672,41.1008 L 51.7474,43.0815' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 51.7474,43.0815 L 53.2276,45.0621' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 51.7117,40.9473 L 52.7478,42.3338' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-18' d='M 52.7478,42.3338 L 53.784,43.7203' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29' d='M 54.7713,36.2795 L 57.3025,37.0643' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-29' d='M 57.3025,37.0643 L 59.8337,37.8492' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19' d='M 54.9075,45.7963 L 57.4127,44.9448' style='fill:none;fill-rule:evenodd;stroke:#4284F4;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-19' d='M 57.4127,44.9448 L 59.9179,44.0933' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20' d='M 59.9179,44.0933 L 59.8337,37.8492' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-20' d='M 58.6565,43.1735 L 58.5976,38.8027' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-21' d='M 59.8337,37.8492 L 64.8358,34.1109' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-22' d='M 64.8358,34.1109 L 70.5743,36.5737' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-23' d='M 70.5743,36.5737 L 75.9398,33.3788' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-30' d='M 70.5743,36.5737 L 71.9549,42.6639' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-24' d='M 75.9398,33.3788 L 80.6364,37.4943' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-25' d='M 80.6364,37.4943 L 78.1736,43.2328' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<path class='bond-26' d='M 78.1736,43.2328 L 71.9549,42.6639' style='fill:none;fill-rule:evenodd;stroke:#3B4143;stroke-width:2px;stroke-linecap:butt;stroke-linejoin:miter;stroke-opacity:1' />
<text dominant-baseline="central" text-anchor="end" x='13.7124' y='52.7332' style='font-size:2px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#E84235' ><tspan>HO</tspan></text>
<text dominant-baseline="central" text-anchor="start" x='21.4778' y='47.1994' style='font-size:2px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#E84235' ><tspan>O</tspan></text>
<text dominant-baseline="central" text-anchor="middle" x='53.8693' y='36.312' style='font-size:2px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#4284F4' ><tspan>N</tspan></text>
<text dominant-baseline="central" text-anchor="start" x='53.1753' y='34.2304' style='font-size:2px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#4284F4' ><tspan>H</tspan></text>
<text dominant-baseline="central" text-anchor="middle" x='54.0055' y='46.4151' style='font-size:2px;font-style:normal;font-weight:normal;fill-opacity:1;stroke:none;font-family:sans-serif;fill:#4284F4' ><tspan>N</tspan></text>
</svg>
 OC(=O)C1=CC=CC=C1C(C=C1)=CC=C1CCC(N1)=NC=C1CC1CCCC1 OENIXTHWZWFYIV-UHFFFAOYSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 210000003038 Endothelium Anatomy 0.000 description 1
- 206010020880 Hypertrophy Diseases 0.000 description 1
- 206010024770 Local swelling Diseases 0.000 description 1
- 210000004698 Lymphocytes Anatomy 0.000 description 1
- 210000000865 Mononuclear Phagocyte System Anatomy 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 210000002381 Plasma Anatomy 0.000 description 1
- 231100000614 Poisons Toxicity 0.000 description 1
- 206010048591 Post thrombotic syndrome Diseases 0.000 description 1
- 208000000856 Postphlebitic Syndrome Diseases 0.000 description 1
- 208000009146 Rhinoscleroma Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 210000001138 Tears Anatomy 0.000 description 1
- 206010043595 Thrombophlebitis superficial Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 1
- 108010001801 Tumor Necrosis Factor-alpha Proteins 0.000 description 1
- 102000001700 Type I Tumor Necrosis Factor Receptors Human genes 0.000 description 1
- 108010068923 Type I Tumor Necrosis Factor Receptors Proteins 0.000 description 1
- 102000006938 Type II Tumor Necrosis Factor Receptors Human genes 0.000 description 1
- 108010047643 Type II Tumor Necrosis Factor Receptors Proteins 0.000 description 1
- 206010068760 Ulcers Diseases 0.000 description 1
- 206010047073 Vascular fragility Diseases 0.000 description 1
- 210000003462 Veins Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000000240 adjuvant Effects 0.000 description 1
- 239000002671 adjuvants Substances 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 230000002429 anti-coagulation Effects 0.000 description 1
- 239000003146 anticoagulant agents Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 238000006243 chemical reactions Methods 0.000 description 1
- 230000001684 chronic Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000000916 dilatatory Effects 0.000 description 1
- 238000005755 formation reactions Methods 0.000 description 1
- 239000007789 gases Substances 0.000 description 1
- 230000001771 impaired Effects 0.000 description 1
- 230000002757 inflammatory Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effects Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquids Substances 0.000 description 1
- 238000000034 methods Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000000242 pagocytic Effects 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 244000052769 pathogens Species 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- 229920000573 polyethylenes Polymers 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substances Substances 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 230000001256 tonic Effects 0.000 description 1
- 239000003440 toxic substances Substances 0.000 description 1
- 231100000397 ulcers Toxicity 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Abstract
Description
七味通脉热敷贴及其对输液性静脉炎的防治
技术领域:
本发明涉及中药外用酊剂热敷贴,是针对输液性静脉炎,釆 用中药酊剂与新型快速产热剂同袋分隔后组成热敷贴,进行静脉 炎患处持续热敷,使热助药性,药借热力,药物和物理方法相结 合,药物可直达病所,作用迅速而持久,起到活血化瘀,清热散 结,消肿止痛的作用,收到了事半功倍的功效,从而达到预防和 治疗输液性静脉炎的效果。属于医疗护理领域。 背景技术:
静脉输液既是基础护理操作的重要内容,也是临床疾病护理 的重要手段,在临床疾病的抢救、治疗和康复中有着重要作用。 由于静脉内长期输入浓度较高、剌激性较强的药物,或放置剌激 性大的塑料管而引起的化学性或机械性的局部炎症;也可因在输 液过程中,无菌操作不严格而引起局部静脉的感染,而导致静脉 炎的发生。表现为沿浅静脉走向出现条索状红线,局部组织发红、 肿胀、灼热、疼痛,有时伴有畏寒、发热等全身症状。目前,静 脉输液的患者中近80%发生了不同程度的静脉炎。静脉炎可因治 疗不善而出现局部慢性硬结、静脉硬化、闭塞、静脉炎后综合征, 甚至形成溃疡,给患者带来巨大的痛苦,也给护理人员静脉穿刺 造成很大的困难,甚至影响药裨的输入而延误治疗。如何降低静脉炎的发生率和更有效的治疗己发生的静脉炎, 一直是国内外护 理界关心和亟待解决的临床问题。
为了解决上述问题,针对输液所致静脉炎的特点,设计研究 了中药"七味通脉热敷贴",并用"七味通脉热敷贴"患处热敷, 进行输液性静脉炎临床治疗及预防。
发明内容:
本发明的目的,就是提供一种输液性静脉炎的临床治疗及预 防方法。
"七味通脉热敷贴"的制作:本发明制备工艺简单,由内装中药 酊剂的药袋l、加热袋2和敷贴胶带3组成,装入塑料袋密封备 用。本发明是一种中药外用酊剂热敷贴,是针对输液性静脉炎的 特点,对静脉炎患处持续热敷,从而达到预防和治疗静脉炎的目 的。方药组成:当归20g芒硝20g大黄10g玄参20g冰片0. 5g 栀子15g桂枝12g 50%乙醇50ml。方以当归、芒硝为君,当归 甘温,活血化瘀,消肿止痛,补血生肌,能够扩张外周血管,改 善微循环,并能促进受损的血管修复;芒硝咸寒,清热解毒,软 坚散结,对网状内皮系统有明显的刺激作用,使其增生现象与吞 噬能力有所增强,加强抗炎作用,通过刺激神经反射使局部血流 供应丰富,加快淋巴细胞生成,有消炎镇痛作用。冰片味辛苦性 凉,清热止痛,散热结,"芳香开窍",性走而不守,能够增强药 物的渗透作用,使药物得到比较充分的吸收;大黄性寒味苦,清 热结,消肿胀,能"去瘀生新",促进血管内皮修复再生,能够降低毛细血管通透性,改善血管脆性,减少渗出,减轻局部肿胀
疼痛,近年来实验研究发现,大黄可抑制病理状态下TNFR1、 TNFR2表达,降低血浆TNF- a水平,抑制组织炎症反应,同时
能降低系统炎症反应给局部组织所构成的"炎性负荷"。玄参咸 寒,抗凝及抑制血栓形成,防止血栓性浅静脉炎,且能够增强芒 硝的清热散结的作用;栀子苦寒,凉血消肿止痛,四味共为臣药。 桂枝辛散温通,能够温通经脉,开结散郁,桂枝为气分药,气为 血之帅,气行则血行,在大队苦寒药中加入温热药,在血分药中 加入气分药,使全方皆活;乙醇具有辛散温通,行药势作用,能 够扩张血管,促进血液循环,二者共为佐使药。诸药合用,共奏 活血化瘀,清热散结,消肿止痛之效;给药途径为局部持续外敷, 采用加热袋持续加热,使热助药性,药借热力,药物和物理方法 相结合,药物可直达病所,作用迅速而持久,收到了事半功倍的 功效。以上中药经乙醇提炼为酊剂,使用时将中药酊剂10ml经 加药口加入药袋,与新型快速产热剂同袋分隔后组成热敷贴。 附图说明:下面结合附图和实施对本发明做进一步说明,图1、 图2是本发明的结构示意图。
实施:将"七味通脉热敷贴"的加热袋(1)、药袋(2)和敷贴 胶带(3)从聚乙烯袋中取出,轻摇数次加热袋使其开始产热逐 渐升温;将中药酊剂10ml从药袋的加药口 (4)中缓慢加入,将 药袋治疗面(5),平整贴放于静脉炎患处的皮肤上,撕去敷贴胶 带(3)两侧的隔粘纸,使其与皮肤粘牢即可。每4〜5h轻揉加热袋内的加热剂,使其疏松透气并持续产热,24h更换"七味通 脉热敷贴"1次,5d为一疗程。
"七味通脉热敷贴"价格低廉,方法简便,无皮肤刺激等副作 用,值得在临床上推广。
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2009100144261A CN101607000A (zh) | 2009-02-14 | 2009-02-14 | 七味通脉热敷贴及其对输液性静脉炎的防治 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNA2009100144261A CN101607000A (zh) | 2009-02-14 | 2009-02-14 | 七味通脉热敷贴及其对输液性静脉炎的防治 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101607000A true CN101607000A (zh) | 2009-12-23 |
Family
ID=41481010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2009100144261A CN101607000A (zh) | 2009-02-14 | 2009-02-14 | 七味通脉热敷贴及其对输液性静脉炎的防治 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101607000A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101926868A (zh) * | 2010-09-06 | 2010-12-29 | 韩淑红 | 一种预防和治疗化疗药物所致静脉炎的外用中药 |
CN103127463A (zh) * | 2013-03-09 | 2013-06-05 | 牛玉玲 | 静脉炎外敷中药制剂 |
-
2009
- 2009-02-14 CN CNA2009100144261A patent/CN101607000A/zh not_active Application Discontinuation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101926868A (zh) * | 2010-09-06 | 2010-12-29 | 韩淑红 | 一种预防和治疗化疗药物所致静脉炎的外用中药 |
CN101926868B (zh) * | 2010-09-06 | 2012-01-18 | 韩淑红 | 一种预防和治疗化疗药物所致静脉炎的外用中药 |
CN103127463A (zh) * | 2013-03-09 | 2013-06-05 | 牛玉玲 | 静脉炎外敷中药制剂 |
CN103127463B (zh) * | 2013-03-09 | 2014-05-07 | 枣庄市立医院 | 静脉炎外敷中药制剂 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102961729B (zh) | 一种治疗静脉曲张、血栓闭塞性脉管炎及静脉炎的外用中药 | |
CN103142953A (zh) | 一种泡脚保健中药粉剂 | |
CN101972453B (zh) | 一种治疗风湿类风湿关节炎的中药药酒及其制备方法 | |
CN101912572A (zh) | 一种多效外用膏药 | |
CN102327478B (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN102614387B (zh) | 预防和治疗脑中风的中药组合及制备方法 | |
CN103417790B (zh) | 治疗脑出血的中药 | |
CN101347536B (zh) | 治疗跌打损伤的外用制剂 | |
CN1785389A (zh) | 一种治疗溃疡性直肠炎的中药制备方法 | |
CN102698002B (zh) | 一种治疗风湿、类风湿、颈肩腰腿疼的药酒 | |
CN102293967B (zh) | 一种治疗湿疹的药物 | |
CN103191291B (zh) | 一种治疗病毒性心肌炎的中药组合物 | |
CN102166278B (zh) | 一种治疗小儿类风湿性关节炎的中药组合物及其制备方法 | |
CN105168984A (zh) | 一种治疗眼科疾病的中医复方视力贴 | |
CN102309534A (zh) | 一种治疗烧烫伤的中草药组合物及其制备和应用 | |
CN104825801A (zh) | 一种预防和治疗心脑血管疾病的中药制剂 | |
CN101987114A (zh) | 中草药外洗液配方 | |
CN105456989A (zh) | 消除疼痛的中药及其制备方法 | |
CN102526314A (zh) | 一种治疗腹股沟疝的药物及制备方法 | |
CN101683441A (zh) | 一种活血解瘀中药组合物 | |
CN103431940A (zh) | 具有腰肾养护功能的保健发热带 | |
CN103263551A (zh) | 一种消肿化瘀的外用药散 | |
CN103860591A (zh) | 一种用于痔疮脱落后生肌敛疮的外用苗药及其制备方法 | |
CN101204440B (zh) | 一种治疗静脉曲张的药物 | |
CN102274385B (zh) | 一种治疗鼻窦炎的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C06 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Open date: 20091223 |
|
C02 | Deemed withdrawal of patent application after publication (patent law 2001) |